JP2012530073A5 - - Google Patents

Download PDF

Info

Publication number
JP2012530073A5
JP2012530073A5 JP2012515290A JP2012515290A JP2012530073A5 JP 2012530073 A5 JP2012530073 A5 JP 2012530073A5 JP 2012515290 A JP2012515290 A JP 2012515290A JP 2012515290 A JP2012515290 A JP 2012515290A JP 2012530073 A5 JP2012530073 A5 JP 2012530073A5
Authority
JP
Japan
Prior art keywords
seq
peptide
compound
peptidomimetic
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012515290A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012530073A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2010/000760 external-priority patent/WO2010144968A1/en
Publication of JP2012530073A publication Critical patent/JP2012530073A/ja
Publication of JP2012530073A5 publication Critical patent/JP2012530073A5/ja
Pending legal-status Critical Current

Links

JP2012515290A 2009-06-19 2010-06-18 カゼイン由来のプロテアーゼ阻害ペプチド Pending JP2012530073A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2009902841 2009-06-19
AU2009902841A AU2009902841A0 (en) 2009-06-19 Protease inhibitory peptides
PCT/AU2010/000760 WO2010144968A1 (en) 2009-06-19 2010-06-18 Casein derived protease inhibitory peptides

Publications (2)

Publication Number Publication Date
JP2012530073A JP2012530073A (ja) 2012-11-29
JP2012530073A5 true JP2012530073A5 (enExample) 2013-07-04

Family

ID=43355610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012515290A Pending JP2012530073A (ja) 2009-06-19 2010-06-18 カゼイン由来のプロテアーゼ阻害ペプチド

Country Status (8)

Country Link
US (1) US20110104179A1 (enExample)
EP (2) EP2821414A1 (enExample)
JP (1) JP2012530073A (enExample)
KR (1) KR20120027535A (enExample)
CN (1) CN102459321A (enExample)
AU (1) AU2010262763A1 (enExample)
CA (1) CA2765423A1 (enExample)
WO (1) WO2010144968A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2652957A1 (en) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
CN102652831A (zh) 2007-07-12 2012-09-05 口腔健康澳洲私人有限公司 生物膜的免疫治疗
EP2638905B1 (en) 2007-07-12 2019-01-16 Oral Health Australia Pty Ltd Biofilm treatment
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108840927B (zh) * 2018-06-06 2022-07-29 湖南生达生物科技有限公司 弹性蛋白酶抑制剂lnsp-i及其应用
US20220119496A1 (en) * 2019-02-15 2022-04-21 Andrzej Marek RAPAK Inhibitors of cysteine peptidases isolated from natural raw materials and use of the inhibitors in medicine and veterinary medicine
JP6797966B2 (ja) * 2019-04-24 2020-12-09 森永乳業株式会社 胃内酸性プロテアーゼ酵素活性阻害剤、ラクトフェリン組成物の製造方法、及びラクトフェリン組成物
MX2021012778A (es) * 2019-04-26 2021-11-18 Colgate Palmolive Co Metodos y composiciones para reducir la tincion de composiciones antibacterianas para el cuidado bucal.
US11013677B2 (en) 2019-04-26 2021-05-25 Colgate-Palmolive Company Methods and compositions to reduce staining for antibacterial oral care compositions
KR20220034563A (ko) * 2020-09-11 2022-03-18 한국생명공학연구원 신규 치주 질환 특이 항체 및 이의 용도
KR102476515B1 (ko) * 2020-09-11 2022-12-12 한국생명공학연구원 치주 질환 특이 항체 및 이의 용도
US20250334583A1 (en) * 2022-05-24 2025-10-30 Shimadzu Corporation Method for preparing sample solution containing neurogranin-related peptide and method for analyzing neurogranin-related peptide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
JP3567012B2 (ja) * 1995-03-28 2004-09-15 雪印乳業株式会社 新規ペプチド及びその利用
AUPP051497A0 (en) * 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
EP1359157A1 (en) * 2002-04-29 2003-11-05 Société des Produits Nestlé S.A. Metallo-proteinase inhibitory agent
CA2481489A1 (en) * 2002-11-29 2004-06-17 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
KR20070026372A (ko) * 2003-12-19 2007-03-08 더 유니버시티 오브 멜버른 항미생물 조성물
KR20070007128A (ko) * 2004-03-01 2007-01-12 펩테라 파마슈티컬스 엘티디. 카제인 파생 펩타이드들과 그의 치료적 사용들
MY162557A (en) * 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection

Similar Documents

Publication Publication Date Title
RU2012140704A (ru) Способ профилактики и/или лечения фиброза и/или помутнения роговицы (варианты), способ получения фармацевтической композиции для профилактики и/или лечения фиброза и/или помутнения роговицы и глазная фармацевтическая композиция
JP2015517488A5 (enExample)
US9050323B2 (en) Methods of treating destructive inflammation of the mucous membranes with lactoferrin
EA201490809A1 (ru) Способы и композиции для лечения неэффективного эритропоэза
ES2682670T3 (es) Lisinas de bacteriófagos de Streptococcus para la detección y tratamiento de bacterias gram positivas
MX340015B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
JP2012523438A5 (enExample)
NZ627372A (en) Clostridium histolyticum enzymes and methods for the use thereof
JP2012530130A5 (enExample)
JP2012529293A5 (enExample)
JP2017526627A5 (enExample)
NZ610620A (en) Inhibitors of apoptosis and uses thereof
JP2015514778A5 (enExample)
RU2013126581A (ru) Мутанты стрептокиназы и их ковалентно модифицированные формы
ES2955834T3 (es) Variantes de plantaricina nc8alphabeta
WO2011149964A3 (en) Methods for treating or preventing vascular graft failure
JP2018509388A5 (enExample)
JP7562167B2 (ja) 歯周疾患または脱臼性外傷歯の予防もしくは治療用薬学的組成物
JP2018532748A5 (enExample)
AR073810A1 (es) Polipeptidos que tienen actividad antimicrobiana
RU2012136724A (ru) Лечение или профилактика инфекции
TW201129361A (en) Methods for treating pain